Literature DB >> 15378788

Diagnostic role of secretin-enhanced MRCP in patients with unsuccessful ERCP.

László Czakó1, Tamás Takács, Zita Morvay, László Csernay, János Lonovics.   

Abstract

AIM: To evaluate the value of MR cholangiopancreatography (MRCP) in patients in whom endoscopic retrograde cholangiopancreatography (ERCP) was unsuccessfully performed by experts in a tertiary center.
METHODS: From January 2000 to June 2003, 22 patients fulfilled the inclusion criteria. The indications for ERCP were obstructive jaundice (n = 9), abnormal liver enzymes (n = 8), suspected chronic pancreatitis (n = 2), recurrent acute pancreatitis (n = 2), or suspected pancreatic cancer (n = 1). The reasons for the ERCP failure were the postsurgical anatomy (n = 7), duodenal stenosis (n = 3), duodenal diverticulum (n = 2), and technical failure (n = 10). MRCP images were evaluated before and 5 and 10 min after i.v. administration of 0.5 IU/kg secretin.
RESULTS: The MRCP images were diagnosed in all 21 patients. Five patients gave normal MR findings and required no further intervention. MRCP revealed abnormalities (primary sclerosing cholangitis, chronic pancreatitis, cholangitis, cholecystolithiasis or common bile duct dilation) in 10 patients, who were followed up clinically. Four patients subsequently underwent laparotomy (hepaticojejunostomy in consequence of common bile duct stenosis caused by unresectable pancreatic cancer; hepaticotomy+Kehr drainage because of insufficient biliary-enteric anastomosis; choledochojejunostomy, gastrojejunostomy and cysto-Wirsungo gastrostomy because of chronic pancreatitis, or choledochojejunostomy because of common bile duct stenosis caused by chronic pancreatitis). Three patients participated in therapeutic percutaneous transhepatic drainage. The indications were choledocholithiasis with choledochojejunostomy, insufficient biliary-enteric anastomosis, or cholangiocarcinoma.
CONCLUSION: MRCP can assist the diagnosis and management of patients in whom ERCP is not possible.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15378788      PMCID: PMC4576267          DOI: 10.3748/wjg.v10.i20.3034

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  28 in total

1.  How can we reduce complication rates and enhance success rates in Billroth II patients during endoscopic retrograde cholangiopancreatography?

Authors:  S Mosca
Journal:  Endoscopy       Date:  2000-07       Impact factor: 10.093

Review 2.  Diagnostic ERCP.

Authors:  T Ponchon; F Pilleul
Journal:  Endoscopy       Date:  2002-01       Impact factor: 10.093

Review 3.  Can MRCP replace ERCP?

Authors:  Y Takehara
Journal:  J Magn Reson Imaging       Date:  1998 May-Jun       Impact factor: 4.813

4.  Evaluation of pancreatic exocrine function by secretin-enhanced magnetic resonance cholangiopancreatography.

Authors:  L Czakó; J Endes; T Takács; K Boda; J Lonovics
Journal:  Pancreas       Date:  2001-10       Impact factor: 3.327

5.  Magnetic resonance cholangiopancreatography: interest of IV secretin administration in the evaluation of pancreatic ducts.

Authors:  N Nicaise; O Pellet; T Metens; J Devière; P Braudé; J Struyven; C Matos
Journal:  Eur Radiol       Date:  1998       Impact factor: 5.315

6.  Magnetic resonance-cholangiopancreatography in the diagnosis of biliopancreatic diseases.

Authors:  D Lomanto; P Pavone; A Laghi; V Panebianco; P Mazzocchi; F Fiocca; E Lezoche; R Passariello; V Speranza
Journal:  Am J Surg       Date:  1997-07       Impact factor: 2.565

Review 7.  Magnetic resonance cholangiopancreatography.

Authors:  F V Coakley; L H Schwartz
Journal:  J Magn Reson Imaging       Date:  1999-02       Impact factor: 4.813

Review 8.  Pancreatitis.

Authors:  R M S Mitchell; M F Byrne; J Baillie
Journal:  Lancet       Date:  2003-04-26       Impact factor: 79.321

9.  A comparison of ultrasound, computed tomography and endoscopic retrograde cholangiopancreatography in the differential diagnosis of benign and malignant jaundice and cholestasis.

Authors:  P A Pasanen; K P Partanen; P H Pikkarainen; E M Alhava; E K Janatuinen; A E Pirinen
Journal:  Eur J Surg       Date:  1993-01

10.  Magnetic resonance cholangiography: comparison with endoscopic retrograde cholangiopancreatography.

Authors:  J A Soto; M A Barish; E K Yucel; D Siegenberg; J T Ferrucci; R Chuttani
Journal:  Gastroenterology       Date:  1996-02       Impact factor: 22.682

View more
  5 in total

Review 1.  Management of afferent loop obstruction: Reoperation or endoscopic and percutaneous interventions?

Authors:  Konstantinos Blouhos; Konstantinos Andreas Boulas; Konstantinos Tsalis; Anestis Hatzigeorgiadis
Journal:  World J Gastrointest Surg       Date:  2015-09-27

Review 2.  The physiological roles of secretin and its receptor.

Authors:  Syeda Afroze; Fanyin Meng; Kendal Jensen; Kelly McDaniel; Kinan Rahal; Paolo Onori; Eugenio Gaudio; Gianfranco Alpini; Shannon S Glaser
Journal:  Ann Transl Med       Date:  2013-10

3.  Prospective comparison of secretin-stimulated magnetic resonance cholangiopancreatography with manometry in the diagnosis of sphincter of Oddi dysfunction types II and III.

Authors:  Stephen P Pereira; Alice Gillams; Spiros N Sgouros; George J M Webster; Adrian R W Hatfield
Journal:  Gut       Date:  2006-09-27       Impact factor: 23.059

Review 4.  Endoscopic characteristics and usefulness of endoscopic dilatation of anastomotic stricture following pancreaticojejunostomy: case series and a review of the literature.

Authors:  Akihiko Kida; Yukihiro Shirota; Yuji Houdo; Tokio Wakabayashi
Journal:  Therap Adv Gastroenterol       Date:  2016-08-23       Impact factor: 4.409

5.  Role of secretin-enhanced magnetic resonance cholangiopancreatography in the evaluation of patients following pancreatojejunostomy.

Authors:  Munazza Anis; Koenraad Mortele
Journal:  J Clin Imaging Sci       Date:  2013-02-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.